nivolumab
Commercial- Indications
- Melanoma, Non-small cell lung cancer, Renal cell carcinoma, Hepatocellular carcinoma
Company intelligence / Profile preview
Over 300 clinical trials performed in more than 35 countries. Recognized expertise in regulatory processes and site management across Middle East & Africa and Pakistan. Strong track record with international pharma and biotech sponsors. No direct drug development or clinical results as it is a service provider
4 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MCT CRO.